As card brands pressure processors to decline or cancel peptide merchant accounts, 2nd Amendment Processing continues helping eligible businesses explore ACH and cryptocurrency payment options.

Across the peptide, compounding, telehealth, wellness, and research industries, businesses are reporting a troubling pattern: terminated merchant accounts, frozen funds, rejected applications, excessive reserves, and sudden restrictions tied to peptide-related products. These actions can financially cripple a lawful business—sometimes without a meaningful explanation, individualized review, or opportunity to appeal. The time has come to determine whether these were independen

Mastercard has added transaction and volume fees for businesses classified as specialty merchants. In 2ndAP’s view, this is a pure money grab: the published guidance identifies new charges, but no new merchant-facing fraud-prevention service or measurable protection purchased by those fees.

Eli Lilly’s tirzepatide patent should not become a blanket ban on peptide processing. We examine Visa’s penalties, corporate pressure, and the growing threat of financial deplatforming.

2nd Amendment Processing has partnered with accept.blue to expand our payment gateway, e-commerce, CRM, ERP, ACH, invoicing and point-of-sale integration capabilities.

2nd Amendment Processing has partnered with Biller Genie to help businesses automate accounts receivable, streamline invoicing and collections, integrate payments with accounting software, and get paid faster.

Developers building payments for firearms, tobacco and other restricted industries must solve the underwriting architecture before writing checkout code. This guide explains merchant accounts, PayFacs, tokenization, vaulting, webhooks, recurring payments and the 2ndAP Gateway API.